Form 8-K - Current report:
SEC Accession No. 0001628280-25-031624
Filing Date
2025-06-16
Accepted
2025-06-16 16:47:28
Documents
12
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20250610.htm   iXBRL 8-K 39326
  Complete submission text file 0001628280-25-031624.txt   159439

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20250610.xsd EX-101.SCH 1795
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20250610_lab.xml EX-101.LAB 22994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20250610_pre.xml EX-101.PRE 13115
14 EXTRACTED XBRL INSTANCE DOCUMENT cort-20250610_htm.xml XML 2874
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 251050793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)